Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

BSE safety

This article was originally published in The Tan Sheet

Executive Summary

Pharmaca Integrative Pharmacy announces removal of dietary supplements containing bovine-derived brain, skull, eye and nerve materials from shelves Feb. 24 as a result of bovine spongiform encephalopathy (BSE, or mad cow disease) safety concerns. Removal affects six "hormonal cognitive and support" products primarily sold to naturopathic practitioners. Pharmaca's action follows FDA's recent announcement of intention to ban a range of bovine-derived materials from food products, including dietary supplements (1"The Tan Sheet" Feb. 2, 2004, p. 9)...

Pharmaca Integrative Pharmacy announces removal of dietary supplements containing bovine-derived brain, skull, eye and nerve materials from shelves Feb. 24 as a result of bovine spongiform encephalopathy (BSE, or mad cow disease) safety concerns. Removal affects six "hormonal cognitive and support" products primarily sold to naturopathic practitioners. Pharmaca's action follows FDA's recent announcement of intention to ban a range of bovine-derived materials from food products, including dietary supplements (1 (Also see "BSE Interim Final Rules To Ban Materials In Certain Supplements" - Pink Sheet, 2 Feb, 2004.), p. 9)....

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS096523

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel